Cowen & Company

Cowen & Company initiated coverage on Quantum Fuel Systems Tech Worldwide Inc (NASDAQ: QTWW) with a Market Perform rating. The target price for Quantum Fuel Systems is set to $3.25. Quantum Fuel Systems shares have dropped 56.59 percent over the past 52 weeks, while the S&P 500 index has...

In a report published Friday, analysts at Cowen & Company maintained their Market Perform rating on Microsoft Corporation (NASDAQ: MSFT), as well as their price target of $49. Despite a difficult PC market, Microsoft posted its Q3 with the revenue and EPS higher than the consensus and the...

Analysts at Cowen & Company initiated coverage on Granite Construction Inc. (NYSE: GVA) with a Outperform rating. The target price for Granite Construction is set to $41. Granite Construction shares have dropped 9.25% over the past 52 weeks, while the S&P 500 index has surged 11.18% in the...

Analysts at Cowen & Company upgraded Philip Morris International Inc. (NYSE: PM) from Market Perform to Outperform. The price target for Philip Morris has been raised from $78 to $97. Philip Morris shares have gained 1.75 percent over the past 52 weeks, while the S&P 500 index has gained...

Analysts at Cowen & Company upgraded Patterson-UTI Energy Inc. (NASDAQ: PTEN) from undefined to Outperform. Patterson-UTI Energy shares have dropped 38.63% over the past 52 weeks, while the S&P 500 index has surged 11.20% in the same period. Patterson-UTI Energy shares fell 4.50% to close...

Cowen & Company analyst Eric Schmidt told CNBC on Wednesday that there had been "some froth" and possible over-extension in the biotech industry. The comments came after a recent sell-off in biotech stocks. Schmidt noted, however, that there was a "rising tide" in...

Analysts at Cowen & Company downgraded Catamaran Corporation (NASDAQ: CTRX) from Outperform to Market Perform. The price target for Catamaran has been raised from $57.00 to $61.50. Catamaran shares have gained 31.90% over the past 52 weeks, while the S&P 500 index has surged 11.42% in the...

Analysts at Cowen & Company initiated coverage on Foot Locker, Inc. (NYSE: FL) with a Outperform rating. The target price for Foot Locker is set to $67. Foot Locker shares have jumped 34.36% over the past 52 weeks, while the S&P 500 index has gained 10.50% in the same period. Foot Locker...

Analysts at Cowen & Company initiated coverage on Nexvet Biopharma Public Limited Company (NASDAQ: NVET) with a Outperform rating. The target price for Nexvet Biopharma is set to $15. Nexvet Biopharma's shares fell 0.69% to close at $10.10 yesterday.

Cowen & Company initiated coverage on Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) with a Outperform rating, acc. to sources. The target price for Alnylam Pharmaceuticals is set to $150. Alnylam Pharmaceuticals shares have gained 28.50% over the past 52 weeks, while the S&P 500 index has...

Analysts at Cowen & Company initiated coverage on Clean Diesel Technologies Inc. (NASDAQ: CDTI) with a Outperform rating. The target price for Clean Diesel Technologies is set to $3. Clean Diesel Technologies shares have dropped 31.14% over the past 52 weeks, while the S&P 500 index has...

Spark Therapeutics Inc (NASDAQ: ONCE), a small-cap gene therapy developer that went public on January 30, is up more than 1.3 percent on Tuesday morning, after several major Wall Street research firms initiated coverage with positive ratings. Related Link: What You Need To Know About The Spark...